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AbstrACt
Objective In 2014/2015, The BMJ and Research 
Involvement and Engagement (RIE) became the first 
journals to routinely include patients and the public in 
the peer review process of journal articles. This survey 
explores the perspectives and early experiences of these 
reviewers.
Design A cross-sectional survey.
setting and participants Patient and public reviewers for 
The BMJ and RIE who have been invited to review.
results The response rate was 69% (157/227) for 
those who had previously reviewed and 31% (67/217) 
for those who had not yet reviewed. Reviewers described 
being motivated to review by the opportunity to include 
the patient voice in the research process, influence the 
quality of the biomedical literature and ensure it meets 
the needs of patients. Of the 157 who had reviewed, 
127 (81%) would recommend being a reviewer to other 
patients and carers. 144 (92%) thought more journals 
should adopt patient and public review. Few reviewers 
(16/224, 7%) reported concerns about doing open review. 
Annual acknowledgement on the journals’ websites was 
welcomed as was free access to journal information. 
Participants were keen to have access to more online 
resources and training to improve their reviewing skills. 
Suggestions on how to improve the reviewing experience 
included: allowing more time to review; better and 
more frequent communication; a more user-friendly 
process; improving guidance on how to review including 
videos; improving the matching of papers to reviewers’ 
experience; providing more varied sample reviews and 
brief feedback on the usefulness of reviews; developing a 
sense of community among reviewers; and publicising of 
the contribution that patient and public review brings.
Conclusions Patient and public reviewers shared 
practical ideas to improve the reviewing experience and 
these will be reviewed to enhance the guidance and 
support given to them.
IntrODuCtIOn 
Peer review has been central to the scien-
tific process for over 300 years.1 2 It plays a 
key role in funding and publication deci-
sions and in improving the accuracy and 
clarity of reported published research. Peer 
review contributes to scientific integrity by 
helping identify robust research and weeding 
out methodologically weak studies. While 
the value and effectiveness of peer review 
continues to be debated vigorously, it is still 
regarded as an essential quality assurance 
mechanism for funding organisations and 
journals, and it is the only widely accepted 
method for research validation.1 3–6 It is there-
fore a deeply entrenched process in interna-
tional funding organisations and high-quality 
journals. By playing a key part in determining 
what research gets funded and published, 
peer review has a pivotal role in determining 
the treatment and interventions patients 
receive and how medicine is practised.
Despite its pivotal role, peer review is crit-
icised on many fronts.1 7 Traditionally, it has 
been a closed process, and the majority of 
journals still practice blinded review. It is 
only recently that there have been calls to 
include the views of all relevant stakeholders, 
including patients and the public. The role of 
patients and the public is also being stepped 
up as coproducers of health and social care 
research not least because their involvement 
has potential to increase the quality and value 
of the research and reduce waste.8 Many grant 
strengths and limitations of this study
 ► The involvement of patients and the public in the 
peerreview process of journal articles is a novel 
initiative.
 ► This is the first study to evaluate the experience of 
patient and public reviewers.
 ► We explore the perspectives of patient and public 
reviewers at two journals with different publishers.
 ► We involved patients and carers in the design, con-
duct and dissemination of this study.
 ► We report only on the early experiences of patient 
and public reviewers, and this may change over 
time.
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funding organisations now incorporate members of the 
public in their review processes or panels, for example, 
the UK’s National Institute for Health Research (NIHR) 
and the Patient-Centered Outcomes Research Insti-
tute (PCORI) in the USA. By contrast, biomedical jour-
nals still do very little to involve patients and the public 
in their peer-review processes. To address this imbalance, 
The BMJ and Research Involvement and Engagement (RIE) 
journals have adopted innovative strategies aimed at 
coproducing their content with patients and the public, 
and both journals have patient editors.9–12 The systematic 
incorporation of patient and public review of research 
manuscripts alongside traditional scientific peer review 
is a key component of these journal patient partnership 
strategies. Patient and public involvement in peer review 
of research manuscripts represents a landmark shift in the 
concept of peer review at journals, reflecting a desire to 
ensure research is appropriate and relevant to end users. 
These journals also practise open peer review where the 
authors and reviewers know each other’s identities, and 
reviews of published articles are published online beside 
the article for readers.
While some patient and public reviewers are able 
to comment on research methodology, their strength 
collectively is in addressing the relevance and impor-
tance of the research to patients and carers and whether 
the treatment or intervention studied or guidance given 
is practicable and acceptable to patients. They can also 
identify challenges patients and carers face; whether 
the outcomes measured in the studies described are 
important to patients and carers and if other outcomes 
or issues should have been considered. They can also 
suggest ways to strengthen papers to make them more 
useful for shared decision making. Contributions will vary 
according to the background, skills and experience of 
the patient and public reviewer, as it does with academic 
reviewers. Some patients and carers may comment on the 
relevance of a study for a particular group, while those 
with academic training and research knowledge might 
comment on methodology. Others may focus on the 
clarity of the reported research and its interpretation to a 
lay audience. All these contributions and others have the 
potential to enhance the quality of the research and its 
uptake in practice.
Academic researchers are encouraged and motivated 
to publish their research as part of career advancement 
in a ‘publish or perish’ environment,13 and reciprocal 
peer reviewing of articles is considered to be a profes-
sional duty.14–17 In marked contrast, patient and public 
reviewers have no professional implicit or explicit obli-
gations to review. With open access publishing and 
non-blinded review, the responsibility of reviewing papers 
may be compounded by the challenge of being identi-
fied as a person with an illness or disability. Both The BMJ 
and RIE offer guidance for patient and public reviewers, 
developed with patient editors, but these have not 
been informed by the experience of patient and public 
reviewers and might not provide the level of support 
some need. In this collaborative survey carried out by The 
BMJ and RIE, with embedded patient involvement, we 
explore the early experiences of our patient and public 
reviewers. Reviewers were asked what motivates them to 
review research articles, if and why they have declined to 
review, their confidence in reviewing, their perceptions of 
open review, their satisfaction with the process, how they 
would like to be acknowledged for their contributions 
and their views on how the process could be improved. 
This knowledge will be used to inform evidence-based 
guidance for patient and public reviewers.
MethODs
sampling
Patients and public reviewers who were registered as 
reviewers for The BMJ or RIE and were invited to review 
for one of the journals at least once between January 2015 
and May 2017 were eligible to participate. The reviewer 
pool was split into two samples based on review history: 
those who had already completed a review and those who 
had been invited but not yet completed a review (by April 
2017). This was so that questions that were not relevant to 
those who had not yet reviewed could be excluded.
Reviewers’ contact details were extracted from the 
relevant manuscript tracking systems and uploaded to 
SurveyMonkey. We excluded those who were registered 
as reviewers but whom had not been invited to review and 
those who have previously asked not to be contacted by 
The BMJ for marketing purposes.
Questionnaire development and pretesting
Survey items were developed by the research team, which 
included patient and public reviewers from both partic-
ipating journals (AD, RH and JE) and The BMJ and RIE 
patient editors (TR, AP and RS). The questionnaires were 
pretested before launching the survey with a further four 
BMJ patient and public reviewers to check the survey 
content was appropriate and addressed issues of impor-
tance to patient and public reviewers and that questions 
were not ambiguous.
survey administration
Reviewers were sent a personalised email invitation to 
complete a survey (online supplementary appendix 
1) administered by SurveyMonkey. There were two 
versions of the questionnaire: those who had already 
completed a review received all the questions and those 
who had not received only a subset. Participants were 
informed that they could choose not to take part and 
withdraw at any time; survey completion was used to 
indicate consent to participate. They were told that the 
results of the survey would be submitted for publication 
and that we may choose to quote from their responses 
but individuals would not be identified. All survey data 
were treated confidentially, and only SS and EF saw 
the individual responses for their own journals. All 
data were deidentified before sharing with the wider 
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research team. Non-respondents were sent up to two 
reminders to take part at 2 and 4 weeks after the initial 
mailing.
Patient involvement
Patient and public reviewers were involved in multiple 
stages of the research. Three patient and public reviewers 
(JE, RH and AD) are coauthors on this paper as they 
were core members of the research team and substan-
tially contributed to the development of the question-
naire, refinement of the questionnaire, interpretation 
of results and manuscript revision. These three patient 
partners coproduced an abstract and poster of the find-
ings for the ‘NIHR-INVOLVE’ Conference 201718 to aid 
dissemination of the research to academic and industry 
research professionals, patients, policy makers, editors 
and advocacy groups. We pretested the questionnaire 
with a further four BMJ patient and public reviewers 
(outside of the research team) and refined the questions 
based on their feedback. Three other members of the 
research team are patient editors with long-term condi-
tions committed to involving patients in research. More 
details can be found in the completed GRIPP2 reporting 
checklist for improving the reporting of patient and 
public involvement in research (see online supplemen-
tary material 2).
results
response rate
One hundred and twenty-two (74%) of the 164 BMJ and 
35 (56%) of the 63 RIE reviewers who had previously 
reviewed responded and 51 (38%) of the 133 BMJ and 16 
(19%) of the 84 RIE reviewers who had not yet reviewed 
responded. We pooled the results for the overlapping 
content and report for both samples combined where 
relevant.
respondent characteristics
Table 1 shows the respondent characteristics for reviewers 
completing the surveys. The majority of reviewers lived 
in the UK. Reviewers who had reviewed had completed 
a median of two reviews. Overall reviewers who had 
reviewed reported spending a median of 5 days a month 
on other patient involvement or engagement activities 
and those who had not yet reviewed reported this as 7 
days a month. However, there were differences between 
the journals with RIE reviewers reporting more days spent 
doing these activities than BMJ reviewers.
Motivation to review
Patient and public reviewers who had already reviewed 
described in free-text comments how they are motivated 
to review by the opportunity to include the patient voice 
in the research process; the opportunity to influence the 
Table 1 Respondent characteristics
Had already reviewed BMJ (n=122)
RIE
(n=35)
All
(n=157)
Median (LQ, UQ) number of reviews completed 2 (1, 4) 2 (1, 3) 2 (1, 4)
Country of residence, n (%) 
  UK 63 (52) 28 (80) 91 (58) 
  Europe (excluding UK) 20 (16) 3 (9) 23 (15) 
  North America 36 (30) 2 (6) 38 (24) 
  Australia/New Zealand 3 (2) 2 (6) 5 (3) 
Median (LQ, UQ) number of days per month 
spent on patient involvement and engagement 
activities
5 (2, 11) 11 (3, 24) 5 (2, 15)
Had not already reviewed
BMJ
(n=51)
RIE
(n=16)
All
(n=67)
Country of residence, n (%) 
  UK 22 (43) 5 (31) 27 (40)
  Europe (excluding UK) 10 (20) 10 (63) 20 (30)
  North America 14 (27) 0 (0) 14 (21)
  Australia/New Zealand 0 (0) 0 (0) 0 (0)
  Asia 1 (2) 0 (0) 1 (1)
Median (LQ, UQ) number of days per month 
spent on patient involvement and engagement 
activities
6 (2, 14) 21 (10, 26) 7 (3, 21)
Percentages do not sum to 100% because of missing data.
LQ, lower quartile; RIE, Research Involvement and Engagement; UQ, upper quartile.
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quality of the literature and to help ensure it meets the 
needs of patients and is understandable by them; helping 
make research more relevant and useful to researchers, 
clinicians and patients; the intellectual challenge; and 
learning more about research on topics of interest to 
them.
Data are presented as the mean (SD) of responses on a 
5-point Likert scale for the n=157 who had reviewed. The 
factor rated most highly in importance to the decision to 
accept a paper to review was the opportunity to add the 
patient or carer perspective (4.49 (0.71)) (figure 1), but 
more than half reported the following as 'very' or 'extremely 
important': the contribution of the paper to the subject 
area (3.8 (0.9)), relevance of the topic to own experi-
ence/interests (3.8, (1.0)), desire to keep up-to-date on 
current research (3.6 (1.0)) and opportunity to learn 
something new from the paper (3.5 (1.0)).
reasons for declining
Data are presented as the mean (SD) of responses on a 
5-point Likert scale. Across both samples, 101 reviewers 
reported that they had declined a request to review at 
some stage. The most highly rated factors important in 
the decision to decline to review was conflict with other 
workload (3.7 (1.4)), a tight deadline for completing the 
review (3.3 (1.4)) and conflicts with family commitments 
or responsibilities (2.8 (1.6)), figure 2. Dislike of the 
open peer-review process (1.1 (0.4)), having to use the 
online manuscript review system (1.3 (0.7)) and lack of 
formal recognition of reviewer contribution (1.3 (0.7)) 
were the least important factors. Other reasons reviewers 
mentioned for declining to review included a lack of 
experience or interest in the topic, the irrelevance of the 
topic for patient and public review in general and not 
understanding the paper.
Confidence in reviewing
Of the 157 who had reviewed, 43 (27%) reported feeling 
either 'not at all' or only 'slightly' confident when doing 
their first review, but this proportion fell for those who 
had done more than one review to 11/141 (8%) when 
doing their last review. Six (4%) reported they were 
'extremely confident' when doing their first review and 19 
(13%) when doing their last review.
Reviewers explained that the following had helped to 
improve their confidence: practice and gaining famil-
iarity with the process; seeing other peer reviewers’ 
comments on the paper; having access to sample 
reviews; receiving feedback from editors; knowing their 
review was valued; being asked to review again; improved 
journal guidance and provision of frequently asked ques-
tions; seeing their own comments in letters to authors 
requesting revisions; and generally reading more peer 
reviewed articles and reviewing for other organisations 
simultaneously.
"It takes time in my estimation to get into a place where as 
a patient I am confident reviewing the work of academic 
scholars. At first I took the stance of ‘who am I to challenge 
them,’ but recognized after the first review I am the patient 
Figure 1 Importance of specific factors in the decision to accept to review (n=157 who had previously reviewed).
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with the experience and perspective that can help to inform 
the practice of research."
"Initially I was worried that my lack of in-depth knowledge 
of statistical methods would make my comments seem petty or 
too simplistic. Yet when I read expert reviewers comments I 
saw that they picked up on some of my points which gave me 
the confidence to stick to my guns and write anything I felt 
was important to say."
Perceptions of open review process
At both journals, all reviewers’ named comments are 
published alongside the article on the journals’ websites. 
When asked if they had concerns about open review, 
181/224 (81%) said no, 16 (5%) said yes and 25 (7%) 
were unsure. Of the 16 who said yes, 15 had already 
reviewed a manuscript. Reported concerns included 
some which were generic to the concept of open review 
(for example worries about being completely critical of a 
paper or misunderstanding something) and some which 
were specific to being a patient (for example  embarrass-
ment or being perceived negatively by others, patient 
confidentiality, misuse of personal information published 
online, implications for future job applications and 
impact on receiving disability benefits).
"I am cautious about who I share information with in terms 
of my health. Just putting my name out there as a patient 
reviewer exposes some of that. I have decided that the benefits 
of being a BMJ peer reviewer are greater to me than the risk of 
exposing myself that way, but it was a consideration."
reviewer satisfaction
Likeliness to recommend to other patients and carers
One hundred and twenty-seven (81%) of the 157 who 
had reviewed (82% BMJ, 77% RIE) would recommend 
being a patient and public reviewer to other patients and 
carers, 3 (2%) would not and 26 (17%) were unsure. 
Reasons for potentially not recommending to others 
included the lack of a sense of community among patient 
and public reviewers, non user-friendly submission soft-
ware and disappointment that the paper reviewed was 
accepted despite their comments that the paper was not 
methodologically strong or well presented. Hesitancy to 
recommend focused on the fact that reviewing is not for 
everyone and that it is a highly subjective exercise.
Should other journals adopt patient and public review?
Based on their reviewing experience so far, 144 (92%) 
of the 157 reviewers (91% BMJ, 94% RIE) thought more 
journals should adopt patient and public review.
"We need to show maturity in academic working and co-cre-
ation with patients and carers. Patients and carers already 
influence whether grants are awarded (millions of pounds) 
so this is another step in closing the evidence to practice 
loop."
Figure 2 Importance of specific factors in the decision to decline to review (n=101 who had previously declined an invitation to 
review).
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"Patients bring a unique perspective to scientific articles. Far 
from being a luxury, patient views are an important factor 
in research relevance."
"… [I]t should prove mutually beneficial and give research-
ers a 'patient's eye view of potential/existing treatments as 
well as suggesting further avenues for research."
"Very good scheme and needs to be developed to be-
come a beacon for other general medical journals."
Hesitancies included worry that patient and public 
review could become a tick box exercise, needing reassur-
ance that patient and public reviewers’ comments were 
being considered and the appropriateness of journal 
content for patient and public review.
Perceptions of authors and other reviewers
Thirty-five (22%) reviewers indicated that they had 
reviewed a paper for which the editors later shared the 
peer reviewers’ comments. Twenty-nine of 35 (83%) 
‘strongly agreed’ or ‘agreed’ that the authors of the paper 
addressed the points they had raised in their reviews 
and 28/35 (80%) ‘strongly agreed’ or ‘agreed’ that the 
authors were courteous when addressing their points. 
After having seen the peer reviewers’ comments on the 
paper they reviewed, 22 (63%) felt they had been able 
to include points important to patients or carers in their 
own review(s) that were not raised by the peer reviewers, 
10 (29%) could not remember or felt it was difficult to 
judge and only three (9%) felt that they were unable to 
do so.
Helpfulness of journal instructions
Overall, 95/157 (61%) who had reviewed perceived 
the current instructions received on what to include in 
the review as ‘extremely’ or ‘very helpful’ (BMJ: 63%, RIE: 
51%); 49 (31%) found them only 'moderately' helpful; and 
13 (8%) 'slightly' or 'not at all' helpful. Reviewers made 
constructive suggestions on how the guidance could be 
improved.
how to acknowledge patient and public reviewers’ help
Patient and public reviewers at both journals are acknowl-
edged annually on the journal websites, and analysis of 
the free-text comments about how reviewers should be 
acknowledged showed this was well received by partici-
pants. All BMJ reviewers receive an annual free subscrip-
tion to the online version of the journal ( bmj. com) as only 
research articles are open access, and this was popular with 
BMJ respondents. RIE is already open access for anyone 
to read. Having access to information was important and 
respondents were keen to receive longer term subscrip-
tions for the journal, the ability to pass it on to a family 
member or subscriptions or access to articles in other 
journals published by BMJ. Participants were also keen to 
have access to more online resources, conferences and 
training to improve their reviewing skills.
"I think I am adequately ‘compensated’ for my work and I 
appreciate the subscription. As an advocate who rarely gets 
paid for my work, journal access is a big deal to me. I do this 
because it's a passion and I want to see the dynamic change. 
I'm doing my part and that's what gratifies me most."
RIE offers patients or service users who have reviewed 
a certain number of articles within any period of 12 
months an Article Processing Charge (APC) waiver for an 
article submitted to the journal. Only three RIE reviewers 
commented on the value of the waiver for the APC. One 
was very positive of its value and had used the APC waiver 
to publish the experience of their patient group in the 
journal, another felt all patient and public reviewers 
should have the APC waived and another that it should 
be transferable to another person.
The majority of free-text comments did not focus on 
monetary incentives, but some reviewers did suggest 
honorariums, payment, gift vouchers, a prize draw and 
donations to charity after accruing reviews. There were 
suggestions that the lack of any form of compensation for 
reviewing might put off some potential patient and public 
reviewers. Others wanted something physical that they 
could show others, for example: a certificate of participa-
tion; a pin badge or keyring for long-standing reviewers; 
a gadget; an annual award for the best reviewer and an 
announcement of this; graded awards (eg, gold, silver and 
bronze) based on reviewer performance; a reward system 
tied to Publons (https:// publons. com/ home); a formal 
letter by post after a fixed number of reviews; and some-
thing to state in their CVs.
In free-text comments, reviewers expressed interest 
in being named as patient and public reviewers on the 
published articles themselves rather than just in the 
accompanying published reviews or for an indication in 
the article that it has been reviewed by patients. Others 
wanted more publicity over the contribution that patient 
and public review brings to the journals, the opportunity 
to contribute patient opinions on published articles or 
to be included as coauthors in commentaries and blogs. 
They suggested a patient and public reviewer Tweet-
Chat led by journal staff, more feedback about how their 
reviews were beneficial and to schedule patient and 
public reviewer meetings in order to build community 
and to develop expertise.
how to improve the experience
Suggestions on how to improve the overall experience 
included: allowing more time to review; improving and 
more frequent communications, for example, by news-
letter; making the submission process and automated 
communications more user friendly; adding more and 
improved guidance on how to review including videos 
of the submission process and explaining what to expect 
and when; better matching of papers to reviewers’ expe-
rience; providing more varied sample reviews; more 
support, encouragement, training and forums to answer 
questions; editors providing (brief) feedback on useful-
ness of reviews and how papers have changed as a result 
of the reviews; better sharing of information around 
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decisions made on manuscripts reviewed; developing a 
sense of community (an online network) among patient 
and public reviewers; peer-to-peer mentoring; raising the 
profile of patient review by illustrating the value added 
and changes made; and treating patient and public 
reviewers as equal partners in the peer-review process.
DIsCussIOn
This is the first study to explore the experience of patient 
and public reviewers involved in the peer-review process of 
academic journals. A large majority of patient and public 
reviewers were enthusiastic about their experience, would 
recommend others to act as reviewers and thought other 
journals should adopt patient and public review. Few 
reported concerns about being identified through open 
review. Reviewers identified areas where the journals 
could improve and how they would like to be acknowl-
edged for their contributions. Annual acknowledgement 
of reviewers’ contributions on the journals’ websites was 
welcomed. BMJ reviewers welcomed the free subscription 
to the journal as a reward for reviewing (all content in 
RIE is open access). Only three RIE reviewers commented 
on the APC waiver. Some reviewers cautioned about 
tokenism and underlined the need for more feedback on 
how patient and public review is valued by authors and 
editors. Fostering a sense of community among patient 
and public reviewers was advocated. Despite the different 
approach and guidelines for patient and public review 
between The BMJ and RIE, the reviewers’ views on most 
issues were similar.
While the motivating factors for academics to review 
papers are known,14–17 this study assessed what motivates 
patients and carers to review. It establishes that the overar-
ching motivating factor is the opportunity to add patient 
or carer perspectives. It is of interest to note that moti-
vating factors reported by academic reviewers were also 
considered important to patient and public reviewers, 
for example, the contribution of the paper to the subject 
area, relevance of the topic to their own experience/
interests, a desire to keep up-to-date on current research 
and the opportunity to learn something new from the 
paper. Similar to academic reviewers, patient and public 
reviewers valued being given an online subscription to 
the journal14 17 and indicated a desire for access to more 
information from journals and publishers. Again, similar 
to academic reviewers, the most important factor in 
declining to review was conflict with other workload,14 but 
a higher proportion of patients reported the tight dead-
line for completing the review affected their decision to 
decline than academics.
The results suggest that it is feasible to introduce patient 
and public review alongside peer review of research 
papers. Patients and the public greatly appreciate the 
opportunity to be involved and see value in it. However, 
they also indicated areas for development and questioned 
some of our practice. This emphasises the importance of 
seeking feedback and making the subsequent changes to 
demonstrate that we value their opinion. Some areas are 
easily fixed, while others are restrained by the software, 
expense or demands of a fast publication process designed 
to meet the needs of authors and researchers. Journals 
do not typically pay peer reviewers. While the majority 
of reviewers did not focus on monetary compensation or 
incentives, some suggested lack of monetary compensa-
tion was a barrier if the goal was to solicit views from a 
fully representative sample of patients. Some organisa-
tions offer patients honoraria for reviewing, for example, 
NICE’s Health Technology Appraisal, although these 
requests are to review documents substantially longer 
than a research paper. Responses to this survey identified 
a range of ways that patient and public reviewers can be 
thanked and acknowledged other than through financial 
compensation.
We received a good response rate of 69% overall for 
those who had previously reviewed, reflecting a high level 
of ongoing engagement and support for this initiative. 
The respondents were involved in other patient involve-
ment activities for an average of 5 days a month reflecting 
the increasingly strong commitment to include the 
patient’s voice in health research and healthcare provi-
sion. RIE reviewers reported spending more time on 
these activities than BMJ reviewers. This finding reflects 
the fact that many of the patient and public reviewers for 
RIE have been recruited from groups already working in 
research, such as the National Cancer Research Institute 
Consumer Forum in the UK or are European Patients' 
Academy Fellows, and thus likely to have experience and 
expertise in critical appraisal of protocols and research 
studies (especially on the patient-related aspects of 
the research). BMJ reviewers are asked to respond to 
a broader patient-specific set of questions and are not 
expected to have any research experience. Despite these 
differences, responses to the surveys were so similar 
for both journals that we needed to report only the 
combined response.
Our study is limited by including the experiences of 
patient and public reviewers at only two journals. However, 
these two journals were the first to introduce patient 
and public review alongside academic peer review and 
have sufficient experience of implementing it to enable 
the survey. At the time of the survey, we were not aware 
of any other journals systematically including patients 
in reviewing research papers. The two journals have 
different approaches and guidance, but their reviewers 
report similar experiences and challenges. Some respon-
dents had only limited experience of reviewing and their 
perceptions may change with time. As this is a recent and 
novel initiative, it is important to survey patient and public 
reviewers again as we make changes to the guidance and 
seek to provide them with more support. While respon-
dents did not focus on the need for monetary rewards 
and financial incentives, it is important to acknowledge 
that their views may not be representative of all potential 
patient and public reviewers. Similarly, while open review 
did not appear to be a concern for most patients, we have 
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no way of knowing how many have been deterred from 
reviewing because of this.
Patient and public review of health research is a 
development in response to the call for greater patient 
and public involvement in research and healthcare in 
general. Peer review of research papers happens at the 
end of the research process, and we recognise and agree 
on the importance of involving patients early on at the 
start of the research process and throughout it to increase 
its value and minimise waste in research19 20 and to help 
make evidence more relevant and accessible to end 
users.21–25The BMJ and RIE see partnering with patients, 
their carers, wider support networks and the public as an 
ethical imperative essential to improving the quality, safety, 
value and sustainability of health systems.9–12 26 Patient 
and public review is just a single initiative under these 
partnership strategies the journals have introduced. Both 
journals also have patients and carers as members of their 
editorial boards and patient editors to bring the patients’ 
perspective to internal discussions and decision making. 
The results of this survey will be used to help improve 
the guidance, support and ultimately the experience of 
patient and public reviewers for the participating jour-
nals and other journals that adopt it. Further research 
is planned to identify where and how patient and public 
reviewers add value to the peer review process.
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